Micro RNA Expression and Prognosis in Low-grade Non-invasive Urothelial Carcinoma
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | DIP, Nelson | |
dc.contributor.author | REIS, Sabrina T. | |
dc.contributor.author | ABE, Daniel K. | |
dc.contributor.author | VIANA, Nayara I. | |
dc.contributor.author | MORAIS, Denis R. | |
dc.contributor.author | MOURA, Caio M. | |
dc.contributor.author | KATZ, Betina | |
dc.contributor.author | SILVA, Iran A. | |
dc.contributor.author | SROUGI, Miguel | |
dc.contributor.author | LEITE, Katia R. M. | |
dc.date.accessioned | 2015-07-01T20:15:59Z | |
dc.date.available | 2015-07-01T20:15:59Z | |
dc.date.issued | 2014 | |
dc.description.abstract | Purpose: To analyze a possible correlation between a miRNA expression profile and important prognostic factors for pTa urothelial carcinomas (UC), including tumor size, multiplicity and episodes of recurrence. Materials and Methods: Thirty low-grade non-invasive pTa bladder UC from patients submitted to transurethral resection were studied, in a mean follow-up of 17.7 months. As controls, we used normal bladder tissue from five patients submitted to retropubic prostatectomy to treat benign prostatic hyperplasia. Extraction, cDNA and amplification were performed for 14 miRNAs (miR-100, -10a, -21, -205, -let7c, -143, -145, -221, -223, -15a, -16, -199a and -452) using specific kits, and RNU-43 and -48 were used as endogenous controls. Statistical tests were used to compare tumor size, multiplicity and episodes of recurrence with miRNAs expression profiles. Results: There was a marginal correlation between multiplicity and miR-let7c over- expression. For all others miRNA no correlation between their expression and prognostic factors was found. Conclusion: We did not find differences for miRNAs expression profiles associated with prognostic factors in tumor group studied. The majority of miRNAs are down-regulated, except miR-10a, over-expressed in most of cases, seeming to have increased levels in tumor with more unfavorable prognostic factors. More studies are needed in order to find a miRNA profile able to provide prognosis in pTa UC to be used in clinical practice. | |
dc.description.index | MEDLINE | |
dc.identifier.citation | International Braz J Urol, v.40, n.5, p.644-649, 2014 | |
dc.identifier.doi | 10.1590/S1677-5538.IBJU.2014.05.09 | |
dc.identifier.eissn | 1677-6119 | |
dc.identifier.issn | 1677-5538 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/9236 | |
dc.language.iso | eng | |
dc.publisher | BRAZILIAN SOC UROL | |
dc.relation.ispartof | International Braz J Urol | |
dc.rights | openAccess | |
dc.rights.holder | Copyright BRAZILIAN SOC UROL | |
dc.subject | MicroRNAs | |
dc.subject | Urinary Bladder Neoplasms | |
dc.subject | Prognosis | |
dc.subject | Molecular Biology | |
dc.subject.other | superficial bladder-cancer | |
dc.subject.other | growth-factor receptor-3 | |
dc.subject.other | cell-carcinoma | |
dc.subject.other | gene-mutations | |
dc.subject.other | fgfr3 | |
dc.subject.other | ras | |
dc.subject.other | pathways | |
dc.subject.other | survival | |
dc.subject.other | family | |
dc.subject.other | stage | |
dc.subject.wos | Urology & Nephrology | |
dc.title | Micro RNA Expression and Prognosis in Low-grade Non-invasive Urothelial Carcinoma | |
dc.title.alternative | Micro RNA expression and prognosis in low-grade non-invasive urothelial carcinoma | |
dc.type | article | |
dc.type.category | original article | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.citation.scopus | 8 | |
hcfmusp.contributor.author-fmusphc | NELSON GASPAR DIP JUNIOR | |
hcfmusp.contributor.author-fmusphc | SABRINA THALITA DOS REIS FARIA | |
hcfmusp.contributor.author-fmusphc | DANIEL KANDA ABE | |
hcfmusp.contributor.author-fmusphc | NAYARA IZABEL VIANA MOURA | |
hcfmusp.contributor.author-fmusphc | DENIS REIS MORAIS | |
hcfmusp.contributor.author-fmusphc | CAIO MARTINS MOURA | |
hcfmusp.contributor.author-fmusphc | BETINA STIFELMAN KATZ | |
hcfmusp.contributor.author-fmusphc | IRAN AMORIM DA SILVA | |
hcfmusp.contributor.author-fmusphc | MIGUEL SROUGI | |
hcfmusp.contributor.author-fmusphc | KATIA RAMOS MOREIRA LEITE | |
hcfmusp.description.beginpage | 644 | |
hcfmusp.description.endpage | 649 | |
hcfmusp.description.issue | 5 | |
hcfmusp.description.volume | 40 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 25498275 | |
hcfmusp.origem.scielo | SCIELO:S1677-55382014000500644 | |
hcfmusp.origem.scopus | 2-s2.0-84920065306 | |
hcfmusp.origem.wos | WOS:000348606000009 | |
hcfmusp.publisher.city | RIO DE JANEIRO | |
hcfmusp.publisher.country | BRAZIL | |
hcfmusp.relation.reference | Ali-El-Dein B, 2003, BJU INT, V92, P393, DOI 10.1046/j.1464-410X.2003.04360.x | |
hcfmusp.relation.reference | Bakkar AA, 2003, CANCER RES, V63, P8108 | |
hcfmusp.relation.reference | Borden LS, 2005, CURR OPIN ONCOL, V17, P275, DOI 10.1097/01.cco.0000156985.47984.9e | |
hcfmusp.relation.reference | Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315 | |
hcfmusp.relation.reference | Castillo-Martin M, 2010, UROL ONCOL-SEMIN ORI, V28, P401, DOI 10.1016/j.urolonc.2009.04.019 | |
hcfmusp.relation.reference | Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744 | |
hcfmusp.relation.reference | Cimmino A, 2006, P NATL ACAD SCI USA, V103, P2464, DOI 10.1073/pnas.0510793103 | |
hcfmusp.relation.reference | Dip N, 2012, J UROLOGY, V188, P1951, DOI 10.1016/j.juro.2012.07.004 | |
hcfmusp.relation.reference | Dip N, 2011, J MOL BIOMARK DIAGN, V2, P1 | |
hcfmusp.relation.reference | Enokida H, 2008, INT J CLIN ONCOL, V13, P298, DOI 10.1007/s10147-008-0811-1 | |
hcfmusp.relation.reference | Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705 | |
hcfmusp.relation.reference | Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014 | |
hcfmusp.relation.reference | Lamm DL, 2000, J UROLOGY, V163, P1124, DOI 10.1016/S0022-5347(05)67707-5 | |
hcfmusp.relation.reference | Leite KRM, 2011, UROL ONCOL-SEMIN ORI, V29, P265, DOI 10.1016/j.urolonc.2009.02.002 | |
hcfmusp.relation.reference | Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035 | |
hcfmusp.relation.reference | Lin TX, 2009, J UROLOGY, V181, P1372, DOI 10.1016/j.juro.2008.10.149 | |
hcfmusp.relation.reference | Marsit CJ, 2007, CARCINOGENESIS, V28, P1745, DOI 10.1093/carcin/bgm116 | |
hcfmusp.relation.reference | Martinez-Torrecuadrada JM, 2005, CLIN CANCER RES, V11, P6280, DOI 10.1158/1078-0432.CCR-05-0282 | |
hcfmusp.relation.reference | McConkey DJ, 2010, UROL ONCOL-SEMIN ORI, V28, P429, DOI 10.1016/j.urolonc.2010.04.008 | |
hcfmusp.relation.reference | NARAYANA AS, 1983, J UROLOGY, V130, P56 | |
hcfmusp.relation.reference | Ornitz DM, 1996, J BIOL CHEM, V271, P15292 | |
hcfmusp.relation.reference | Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001 | |
hcfmusp.relation.reference | Pandith AA, 2013, UROL ONCOL-SEMIN ORI, V31, P398, DOI 10.1016/j.urolonc.2010.07.014 | |
hcfmusp.relation.reference | Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138 | |
hcfmusp.relation.reference | SOLOWAY MS, 1980, CANCER, V45, P1856 | |
hcfmusp.relation.reference | van Rhijn BWG, 2001, CANCER RES, V61, P1265 | |
hcfmusp.relation.reference | Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183 | |
hcfmusp.relation.reference | Zhang ZT, 2001, ONCOGENE, V20, P1973, DOI 10.1038/sj.onc.1204315 | |
hcfmusp.scopus.lastupdate | 2024-05-10 | |
relation.isAuthorOfPublication | 7b98028d-1464-41f7-b473-7326a36a8d3c | |
relation.isAuthorOfPublication | 73be4bca-f8ad-443f-90b5-10e2e62b1e27 | |
relation.isAuthorOfPublication | a880b3b6-276f-41d5-bac4-910de6024fcc | |
relation.isAuthorOfPublication | 32f63bee-3f86-4e8d-b307-f29f080dd7b4 | |
relation.isAuthorOfPublication | 7af4bd17-a1d2-4c42-a4af-e0919576a464 | |
relation.isAuthorOfPublication | bc28b381-6994-4655-9f48-9bc7136e4db9 | |
relation.isAuthorOfPublication | 01d7a5da-3983-420d-b86f-291cd9d6378b | |
relation.isAuthorOfPublication | b276e0c0-431e-426d-879c-06108f4cc785 | |
relation.isAuthorOfPublication | cff561dd-5732-4af5-abe9-538da0cdf4d2 | |
relation.isAuthorOfPublication | 23772d3b-0da7-472f-8d56-e6312dbf95c1 | |
relation.isAuthorOfPublication.latestForDiscovery | 7b98028d-1464-41f7-b473-7326a36a8d3c |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_DIP_Micro_RNA_Expression_and_Prognosis_in_Lowgrade_Noninvasive_2014.PDF
- Tamanho:
- 128.91 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)